Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
290
-
Total 13F shares, excl. options
-
107M
-
Shares change
-
-4.35M
-
Total reported value, excl. options
-
$1.91B
-
Value change
-
-$77.9M
-
Put/Call ratio
-
1.22
-
Number of buys
-
119
-
Number of sells
-
-116
-
Price
-
$17.84
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q3 2020
342 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q3 2020.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 290 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 107M shares
.
Largest 10 shareholders include GLENVIEW CAPITAL MANAGEMENT, LLC (16.8M shares), PAULSON & CO. INC. (11.3M shares), Adelphi Capital LLP (8.27M shares), RENAISSANCE TECHNOLOGIES LLC (5.74M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.38M shares), NORTHERN TRUST CORP (4.25M shares), MACQUARIE GROUP LTD (3.97M shares), Parametric Portfolio Associates LLC (3.58M shares), VANGUARD GROUP INC (3.53M shares), and BANK OF AMERICA CORP /DE/ (3.2M shares).
This table shows the top 290 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.